Crestor, after setback in Lipitor trial, may take sales hit
September 02 2011
AstraZeneca's top-selling product, Crestor (rosuvastatin), is looking shaky after results from SATURN, a head-to-head study pitting the statin against Pfizer's ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.